Colgate Palmolive (India) Limited (COLPAL) fair value: what the stock is really worth
We calculate from audited financials what Colgate Palmolive (India) Limited is really worth. The fair value tells you whether the price is too high or too low, the quality score (0 to 100) how solid the business behind it is. 26 models, 37 quality factors, updated daily, free.
Compare price with fair valuebelow fair value = cheap, above = expensive
Check the quality50 and up solid, 75 and up strong
Watch it or check another stockalert when fair value or trend changes
Consumer Defensive · IN · Market cap ₹547B (≈ $5.7B) · ISIN INE259A01022
At a glance
CPColgate Palmolive (India) LimitedCOLPAL · NSE
Price₹1,820
Fair Value₹945.90
Upside−48.0%
Quality80/100
A strong business, but trading 92% above our fair value of ₹945.90.
As of Aug 23, 2026, the fair value of Colgate Palmolive (India) Limited is ₹945.90 per share against a price of ₹1,820, so the fair value sits 48% below the price. A model estimate from reported figures, not an analyst target.
✓Healthy Growth (revenue 5y +4.5 %/yr)
✓Highly profitable · 22.0% net margin
✓Low debt · generates free cash flow
·2.80% dividend yield
✓Ranks above peers (9/14)
✓Wide moat 92/100
Evidence: HighRange ₹695.01 to ₹1,169
Fair value as of: Aug 23, 2026
From 26 valuation models · updated 17 days ago
Share price −10.3% over the past month.
This is the short version. In the app for Colgate Palmolive (India) Limited:
Watch Colgate Palmolive (India) Limited for free, get notified when fair value or trend changes. Plus fair value for all 35,000+ stocks, 14 days of Pro free, no card.Watch for free
69 individual criteria per stock, every one traceable See the method →
What matters now
A high-quality business (quality 80/100), yet the market already pays well above fair value. Quality at a full price, with little margin of safety.
The price sits above even our optimistic bull case (₹1,169). The favourable scenario is already priced in.
Price vs Fair Value (5 years)
White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Aug 23, 2026.
How to read this chart
60‑month range ₹1,259 – ₹3,683 · fair‑value band ₹695.01 – ₹1,169 · the ₹1,820 price screens above the ₹945.90 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). Dashed = 300-day average. As of Aug 23, 2026.
Colgate Palmolive (India) Limited (COLPAL) currently trades at ₹1,820, while our model-based Fair Value estimate is ₹945.90, implying the stock looks roughly 92.4% overvalued today. The Quality Score stands at 80/100 (high quality), in the Consumer Defensive sector. Bull case: the DCF Models group reads highest at a median of ₹1,099 per share, and 0 of the 26 models we run sit above the ₹1,820 price. Bear case: the Economic Profit group reads lowest at ₹257.09, and 26 of the 26 models stay below the price. Evidence for this calculation is high.
Over the trailing twelve months, Colgate Palmolive (India) Limited generated revenue of ₹60.4B at a net margin of 22.0%. Revenue grew 9.1% year over year. It earns a return on equity of 81.6%. The balance sheet holds a net cash position of ₹14.2B. Fundamentals as of Aug 23, 2026
Scenario range: ₹695.01 (bear) to ₹1,169 (bull), the price of ₹1,820 sits above it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target. The share trades about 26% below its 52-week high and 3% above its 52-week low, currently below its 200-day average. For context, the median of 10 Consumer Defensive peers we cover trades at −26% fair-value upside, at −48%, COLPAL screens richer than that median.
Fair Value models
Each model values the company its own way; the fair value above is the evidence-weighted blend. Evidence (0 to 100) shows how complete a model's inputs are. How we calculate →
ModelBear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target.Evidence
Free, no payment details. Unsubscribe anytime in one click.
Key figures & financial health
P/E ratio37.3
P/S ratio8.19P/E × margin
EPS (TTM)₹48.79price ÷ EPS = P/E 37.3
Dividend yield2.8%payout 105%
Net margin22.0%FY2026
Return on equity81.6%TTM
More key figures
Profitability
Return on assets (EBIT)52.0%avg 5y
Operating margin29.8%TTM
Growth
Revenue (TTM)₹60.4BTTM
Revenue growth (YoY)+9.1%3y avg +5.2%
EPS growth (YoY)−0.5%
Balance sheet & cash flow
Free cash flow₹17.9BFY2026
Net cash₹14.2BFY2026
Figures from reported company fundamentals · as of Aug 23, 2026. TTM = trailing twelve months.
Quality Score breakdown
Overall quality80/100
Of which business quality 80
· Market factors (momentum, volatility) 40
Profitability98
Margins and returns on capital today
Quality Growth8
Are margins and returns improving?
Cashflow90
Earnings quality: real cash, not paper profit
Fin. Strength93
Balance sheet, leverage, solvency risk
Investment90
Disciplined investing over empire-building
Low Volatility90
Calm price path (market factor)
Momentum25
Price trend over the last 3–12 months (market factor)
52W Momentum8
Distance to the 52-week high (market factor)
Net Issuance82
Buybacks instead of dilution
Non-valuation factor families (profitability, growth, cashflow, financial strength, momentum …), each academically grounded. Valuation itself sits in the Fair Value and is deliberately excluded here to avoid double-counting.
All values are scores from 0 to 100 (100 = best against fixed, research-based bands), not percentages. The three market factors (momentum, 52-week proximity, low volatility) are displayed but carry zero weight in the headline number: market sentiment is not a business property.
About the company
Colgate-Palmolive (India) Limited manufactures and trades in personal and oral care products in India. The company offers toothpastes, toothpowder, toothbrushes, mouth wash, rinses, hand washes, and shower gels under the Colgate brand name. It also offers soaps, cosmetics, and toilet preparations. In addition, the company exports its products.
Full company description
Colgate-Palmolive (India) Limited manufactures and trades in personal and oral care products in India. The company offers toothpastes, toothpowder, toothbrushes, mouth wash, rinses, hand washes, and shower gels under the Colgate brand name. It also offers soaps, cosmetics, and toilet preparations. In addition, the company exports its products. The company was incorporated in 1937 and is headquartered in Mumbai, India.
Company description, as reported by the company or data provider.
Revenue & earnings trend
FY2022 – FY2026 · reported fiscal years
Colgate Palmolive (India) Limited reported revenue of ₹60.4B in FY2026 versus ₹50.7B in FY2022, a compound +4.5%/yr. Reported net income was ₹13.3B in FY2026, compounding +5.3%/yr from FY2022.
Growth Quality 78/100
Revenue growth appears healthy and is supported by profitability and cash-flow quality.
Latest Revenue (FY 2026)
₹60.4B
Latest YoY
+0.6%
Avg. revenue growth/yr (3Y) ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump.
+5.2%
Avg. revenue growth/yr (5Y) ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump.
+4.5%
Avg. revenue growth/yr (28Y) ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump.
+6.7%
Value creation/yr (5Y, in INR) ⓘEarnings growth per share (CAGR 5 years) plus dividend yield: value created per share and year. Measured in INR: this currency has depreciated against the euro and dollar over the long run, so part of the nominal rate is currency erosion that never reaches a EUR/USD investor.
+7.9%
Earnings growth per share plus dividend yield: the value created per share and year.
Earnings growth per share+5.1%
Dividend yield2.8%
Trend ⓘTwo data points, not a trend model: earnings growth per share over the last 5 fiscal years against the last 10. Labelled "steady" when both rates are within 3 percentage points of each other, otherwise picking up or flattening. Shown only when ten years of history exist.5Y 5.1% vs 10Y 8.7%, flattening
Operating margin (EBIT) ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.27.6% (2021) → 28.6% (2026) · steady
Revenue+4.5%/yr
FY22₹50.7B
FY23₹51.9B
FY24₹56.4B
FY25₹60.0B
FY26₹60.4B
Net income+5.3%/yr
FY22₹10.8B
FY23₹10.5B
FY24₹13.2B
FY25₹14.4B
FY26₹13.3B
Character of growth · EPS growth decomposed (2015-2026)+10.1 % p.a.
Revenue per share+4.6 %
of which total revenue +4.6 % · buybacks/dilution +0.0 %
EBIT margin+4.3 %
Tax rate+0.7 %
Residual (interest, one-offs)+0.2 %
Annual growth per factor. These are factors, not summands: multiplied they give the EPS growth rate, added they do not quite. Start and end points are 3-year averages (details on hover).
For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.
How this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.
Valuation
Quality Score80 · Top 25%
Fair Value upside−55% · Bottom 25%
Profitability
Return on equity (TTM)82% · Top 25%
Return on assets34% · Top 25%
Net margin (TTM)22% · Top 25%
Operating margin (TTM)30% · Top 25%
Growth and dividend
Revenue growth9% · Top 25%
Dividend yield (TTM)2.8% · Above median
Valuation Multiples vs Household & Personal Products median · lower = cheaper
P/E (TTM)37.3× · Priciest 25%
P/B34.54× · Priciest 25%
P/S (TTM)9.07× · Priciest 25%
P/FCF0.3× · Cheaper than median
EV/EBITDA28.7× · Priciest 25%
What the price implies (reverse DCF)
The inverse question: what free-cash-flow growth must Colgate Palmolive (India) Limited deliver for ten years so that today's price is fair in our DCF model? Same formula, same discount rate as the fair value.
Implied FCF growth, 10 years+8.7 % per year
Achieved revenue growth, 5 years+4.5 % p.a.
Sector median revenue growth+2.9 %
FCF yield on price3.61 %
Discount rate (WACC) in the models8.3 %
The price demands an acceleration versus past growth: a high bar the company still has to clear. Ranking of the largest stocks →
Five quick dimensions, each 0 to 100: VALUE (fair-value potential), FUTURE (revenue growth), PAST (return on equity), HEALTH (low debt), DIVIDEND (yield). Green = this stock, grey = typical sector peer.
This stockSector peers
VALUE0· sector 28
FUTURE46· sector 7
PAST100· sector 27
HEALTH100· sector 98
DIVIDEND56· sector 56
VALUE 0: the price sits above our fair-value range.
Insider activity: 28/100
Values & ESG
Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.
None of the checked exposures detected
Similar stocks
10 more Household & Personal Products stocks, each showing price versus our Fair Value estimate (as of Aug 23, 2026).
Is Colgate Palmolive (India) Limited (COLPAL) overvalued or undervalued?
As of Aug 23, 2026, our model estimates a fair value of ₹945.90 versus a price of ₹1,820, about −48% upside (overvalued).
What is the fair value of COLPAL?
Our model-based fair value for Colgate Palmolive (India) Limited is ₹945.90 (as of Aug 23, 2026), built from audited fundamentals. The current price: ₹1,820.
What is the quality score of COLPAL?
Colgate Palmolive (India) Limited has a Quality Score of 80/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Colgate Palmolive (India) Limited (COLPAL)?
Our model-based price target is the fair value of ₹945.90 (as of Aug 23, 2026) from 26 valuation models. Cautious scenario ₹695.01, optimistic scenario ₹1,169. It is a calculation from audited fundamentals, not an analyst target.
What is the Colgate Palmolive (India) Limited stock forecast for 2026?
Our models put fair value at ₹945.90, about −48% upside versus a price of ₹1,820 (overvalued). Cautious scenario ₹695.01, optimistic scenario ₹1,169. The calculation is refreshed regularly with new filings.
What is the revenue of Colgate Palmolive (India) Limited (COLPAL)?
Colgate Palmolive (India) Limited reported trailing-twelve-month revenue of about ₹60.4B (latest available figure, as of Aug 23, 2026).
What is the net profit margin of COLPAL?
The net profit margin of Colgate Palmolive (India) Limited is about 22.0%, meaning it keeps roughly 22.0% of revenue as net income. Based on the latest reported figures.
Does Colgate Palmolive (India) Limited pay a dividend?
Colgate Palmolive (India) Limited currently shows a dividend yield of about 2.80% relative to its recent price (as of Aug 23, 2026).
What growth is priced into Colgate Palmolive (India) Limited (COLPAL)?
For today's price to be fair in a discounted-cash-flow model, Colgate Palmolive (India) Limited would have to grow free cash flow by +8.7 % per year for ten years (discount rate 8.3 %, then 2 % perpetual growth). Over the last 5 years revenue grew +4.5 % per year. As of Aug 23, 2026.
What discount rate (WACC) does the fair value of COLPAL use?
Our models discount Colgate Palmolive (India) Limited at 8.3 %: a base by market capitalisation (mid), damped by beta 0.51. The same rate applies in all 26 models.
What is the intrinsic value of Colgate Palmolive (India) Limited (COLPAL)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Colgate Palmolive (India) Limited it is ₹945.90 per share (as of Aug 23, 2026), against a price of ₹1,820. It is the blended result of 26 valuation models (cash flow, earnings, asset, dividend).
Is Colgate Palmolive (India) Limited stock overvalued or undervalued in 2026?
As of Aug 23, 2026, COLPAL trades above its calculated fair value: price ₹1,820, fair value ₹945.90, a gap of about −48% (overvalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of COLPAL?
No. The price is what the market pays today (₹1,820); the fair value is what the company's own numbers justify (₹945.90). For Colgate Palmolive (India) Limited the two are ₹874.00 per share apart. That gap is exactly why we show both numbers side by side.
How much is Colgate Palmolive (India) Limited worth?
The market values Colgate Palmolive (India) Limited at about ₹547B (market capitalisation, as of Aug 23, 2026). Per share that is ₹1,820; our models calculate a fair value of ₹945.90 per share.
What do the bullish and bearish scenarios say about COLPAL?
Our models span a range for Colgate Palmolive (India) Limited: cautious scenario ₹695.01, base ₹945.90, optimistic ₹1,169 per share (as of Aug 23, 2026, price ₹1,820). The range comes from different growth and margin assumptions, not from analyst opinions.
What is the P/E ratio of COLPAL?
Colgate Palmolive (India) Limited trades at a price-to-earnings ratio of 37.3 (as of Aug 23, 2026). A P/E on its own says little: it compares the price with ONE year of profit, while our fair value of ₹945.90 is built from several models across several years. Other multiples: P/B 34.5, P/S 9.1, EV/EBITDA 28.7.
How solid is the balance sheet of Colgate Palmolive (India) Limited (COLPAL)?
Balance-sheet figures for Colgate Palmolive (India) Limited (as of Aug 23, 2026): return on equity 81.6%. They feed the Quality Score of 80/100, which measures business quality independently of the share price.
How far is COLPAL from its 52-week high?
Colgate Palmolive (India) Limited trades at ₹1,820, about 26% below its 52-week high of ₹2,448 and 3% above the low of ₹1,761 (as of Aug 23, 2026). Distance from the high says nothing about value: that is what the fair value of ₹945.90 is for.
Which stocks are comparable to Colgate Palmolive (India) Limited?
From the same area (Consumer Defensive) we also value L'Oréal S.A, Unilever PLC, 500696, Hindustan Unilever Limited, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Colgate Palmolive (India) Limited stock attractive at the current price?
The data as of Aug 23, 2026: price ₹1,820, calculated fair value ₹945.90 (−48%), Quality Score 80/100, from 26 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of COLPAL calculated?
We run Colgate Palmolive (India) Limited through 26 models from four families: discounted cash flow, earnings models, asset and balance-sheet models, and dividend models. Every model gets the same audited fundamentals; the result is the weighted average of ₹945.90, with the spread shown as a cautious and an optimistic scenario.
Free · no account needed
Watch Colgate Palmolive (India) Limited in the live analysis
One click puts Colgate Palmolive (India) Limited on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 35,000+ stock screener. You can also try 14 days of Pro there, no card.
